Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECIOUS: Amlessa and Co-Amlessa in Hypertension
NCT03738761Phase 4Completed
- Sponsor
- Krka
- Start
- Feb 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 4, open-label trial of amlodipine + perindopril in hypertension (HTN) (2 arms), sponsored by Krka. Primary endpoint: Proportion of patients reaching normal office blood pressure at 16 weeks. Started Feb 2018; status: completed.
02
Drugs
amlodipine + perindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03738761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738761.